Concepedia

Stephen M. Hammond

SM

4

Publications

277

Citations

4

H-Index

1987

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Stephen M. Hammond is an author at AstraZeneca (Sweden) specializing in medicine, biochemistry, and biosynthesis.

Top concepts

MedicineBiochemistryBiosynthesisMicrobiologyAntimicrobial ResistancePharmacologyNatural SciencesMedicinal ChemistryBacteriologyDrug Discovery

Publications per year

1987–1998

4

Publications

4

A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis

Stephen M. Hammond, Alf Claesson, Anita M. Jansson et al. · Nature · 1987 · 155 citations

Biosynthesis, Biochemistry, Natural Product Biosynthesis +6

Aminoalkylphosphinate inhibitors of D-Ala-D-Ala adding enzyme

David J. Miller, Stephen M. Hammond, Daniela Anderluzzi et al. · Journal of the Chemical Society Perkin Transactions 1 · 1998 · 85 citations

Aminoalkylphosphinate Inhibitors, Peptide Science, Pharmacotherapy +17

Design and synthesis of peptide derivatives of a 3-deoxy-D-manno-2-octulosonic acid (KDO) analog as novel antibacterial agents acting upon lipopolysaccharide biosynthesis

Alf Claesson, Anita M. Jansson, Brian G. Pring et al. · Journal of Medicinal Chemistry · 1987 · 26 citations

Bioorganic Chemistry, Lipopolysaccharide Biosynthesis, Pharmaceutical Chemistry +18

Inhibitors of lipopolysaccharide biosynthesis impair the virulence potential of<i>Escherichia coli</i>

Stephen M. Hammond · FEMS Microbiology Letters · 1992 · 11 citations · Full text

Microbial Toxin, Biosynthesis, Gram-negative Bacteriology +15

Rows per page

1–4 of 4